Rebif has not yet been investigated in patients with primary progressive multiple sclerosis and should not be used in such patients.
Rebifi kasutamist primaarse progresseeruva sclerosis multiplex’ iga patsientidel ei ole veel uuritud ja seda ei tohi neil patsientidel kasutada.